Isobutyl iodide → 2,4-Dioxo-1,5-bis-(2-methylpropyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

HRID 965767Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 965767
[O:1]=[C:2]1[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[NH:5][C:4](=[O:13])[CH2:3]1.I[CH2:15][CH:16]([CH3:18])[CH3:17]>>[O:13]=[C:4]1[N:5]([CH2:15][CH:16]([CH3:18])[CH3:17])[C:6]2[CH:12]=[CH:11][CH:10]=[CH:9][C:7]=2[N:8]([CH2:15][CH:16]([CH3:18])[CH3:17])[C:2](=[O:1])[CH2:3]1

Komponenten

3

Edukt 2

HCID 10556Isobutyl iodideHCID 2835341H-1,5-Benzodiazepine-2,4(3H,5H)-dione

Produkt 1

HCID 223127682,4-Dioxo-1,5-bis-(2-methylpropyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

Versuchsvorschrift

2,4-Dioxo-1,5-bis-(2-methylpropyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine was prepared following General Procedure 8-M using the product from Example 8-P, Step A and 1-iodo-2-methylpropane (Aldrich). Purification was by flash chromatography eluting with EtOAc/hexanes (3:7 gradient to 1:1), then recrystalization from EtOAc/hexanes.

Aufarbeitung

  1. customPurification
  2. washeluting with EtOAc/hexanes (3:7 gradient to 1:1)
  3. customrecrystalization from EtOAc/hexanes

Quellen und Nachweise

ORD-Eintrag
ord-f5cb87ee00b349ca9c71da2c63e8a912
Quelldatensatz
uspto-grants-2005_10
Patentnummer
US06951854B1

Notizen zur Reaktion

Wird geladen…